Kvalitet, du kan stole på, resultater, du kan se
Hairgenetix er stolt af at tilbyde banebrydende hårvækstløsninger, der ikke kun er effektive, men også bygger på fuldstændig gennemsigtighed.
Målrettet mod hårtab med præcision
Hos Hairgenetix er vi dedikeret til at revolutionere hårpleje og hårvækst gennem banebrydende innovation. Vores team af forskere og eksperter er engageret i at udvikle effektive løsninger til hårtab og hårtynding med en mission om virkelig at gøre en forskel i de ramtes liv.
Det hele starter med en fuld forståelse af videnskaben bag hårtab. Derefter samler vi den nyeste udvikling inden for teknologi og biovidenskab for at udvikle innovative løsninger, der udnytter naturens kraft i stedet for at modarbejde den.
Hårets vækstcyklus
En klar forståelse af hele hårets vækstcyklus hjælper ikke kun med at løse almindelige hårproblemer, men skelner også mellem, hvad der er typisk, og hvad der kan kræve opmærksomhed. Ved at få indsigt i videnskaben bag hårtab og genvækst kan vi bedre identificere og forebygge de faktorer, der kan forstyrre denne naturlige cyklus. Viden er magt, og med den kan vi tage proaktive skridt til at beskytte og pleje dit hårs naturlige rytme.
Mikroinjektioner for maksimal effektivitet
Mesoterapi tilbyder en overlegen tilgang til hårpleje sammenlignet med traditionelle topiske serummer og dermaruller. Ved hjælp af mikroinjektioner sikres en præcis infusion af hårvækstserummet direkte i hovedbunden, så håret får næring ved rødderne og opnår maksimal effektivitet.
Den patenterede serumpatron, der er udstyret med 12 mikronåle, leverer Advanced Hair Growth Serum direkte i hovedbunden med enestående præcision. Systemet er designet til optimal absorption og forbedrede hårvækstresultater og har justerbar væskeudledning og nåledybde, hvilket giver mulighed for en skræddersyet behandlingsoplevelse, der opfylder individuelle behov.
EMS mikrostrøm-stimulering
Hairgenetix mesoterapi-pennen bruger også det nyeste inden for innovativ EMS-teknologi. Den cirkulære multipolære Level 4-mikrostrøm når dybt ind i huden og stimulerer hår- og hudceller og fremskynder kollagensyntesen. Dette forstærker og forbedrer også effekten af Advanced Hair Growth Serum.
The Science Behind Our Ingredients
Understanding the active compounds that power Hairgenetix hair growth solutions
How copper peptides promote hair growth
Copper peptides are short chains of amino acids bound to a copper ion. The two most researched for hair growth are GHK-Cu and AHK-Cu. They work through three mechanisms:
Angiogenesis — stimulates new blood vessel formation around follicles, increasing oxygen and nutrient delivery.
Anti-inflammation — reduces pro-inflammatory cytokines (TNF-α, IL-6), protecting follicles from chronic inflammation.
Extended growth phase — activates Wnt/β-catenin pathways, extending the anagen phase and delaying regression.
A 2012 review documented GHK-Cu's ability to increase hair follicle size by up to 40%
Pickart, Vasquez-Soltero, and Margolina confirmed that copper peptides reactivate dormant follicles in both men and women, promoting angiogenesis and reducing scalp inflammation at the cellular level.
PDRN activates the adenosine A2A receptor for tissue regeneration
Clinical studies show significant improvements in tissue quality within 4–8 weeks of PDRN treatment. By promoting angiogenesis alongside copper peptides, PDRN amplifies nutrient delivery to the hair follicle.
What is PDRN and why is it in Hairgenetix?
PDRN (Polydeoxyribonucleotide) is a bioactive compound extracted from salmon DNA. It triggers three key responses in the scalp:
Tissue regeneration — promotes fibroblast proliferation and collagen synthesis, rebuilding the extracellular matrix that anchors follicles.
Scalp healing — accelerates repair of micro-damage caused by inflammation, oxidative stress, or microneedling.
Enhanced blood flow — promotes angiogenesis alongside copper peptides, amplifying nutrient delivery to follicles.
Clinical Evidence
Results from the Hairgenetix 150-day clinical trial and published peer-reviewed research
The Hairgenetix clinical trial
In a 150-day clinical trial involving 30 men and women aged 18–65 with various types of hair loss, the Hairgenetix serum achieved:
93% reduction in hair shedding (pull test)
75% of participants reported visible new growth by day 90
70% improvement in hair density (trichoscopy)
90% satisfaction rate at trial completion
All participants used the Meso-Infusion System as directed, with assessments at 30, 60, 90, 120, and 150 days under medical supervision.
Published research supporting hair mesotherapy
Pickart et al. (2012) — GHK-Cu increases follicle size, promotes angiogenesis, reactivates dormant follicles.
Dhurat et al. (2013) — Microneedling significantly improves hair count in androgenetic alopecia.
Mesotherapy Review (2023) — Systematic review confirms efficacy across multiple treatment protocols.
Copper Peptides & Hair (2019) — Copper peptides validated for stimulating hair follicle activity.
Xu et al. (2024) — Microneedling + active compounds shows superior results vs. topical-only.
How mesotherapy compares
Hair Mesotherapy (Hairgenetix) — Micro-infusion of copper peptides + PDRN directly into scalp. At-home, ~€50/month. Results in 2–4 months.
Minoxidil — Topical vasodilator, €20–40/month. Must use indefinitely; scalp irritation common.
Finasteride — Oral DHT blocker, €30–60/month. Prescription only; hormonal side effects.
Alternative treatments
PRP Therapy — Platelet-rich plasma injections, €200–500/session. Clinic only; expensive with mixed evidence.
Low-Level Laser (LLLT) — Red light stimulation, €200–800 device. Modest results; daily use required.
Hair Transplant — Surgical follicle relocation, €3,000–15,000. Invasive; limited donor hair.
Mesotherapy offers a middle ground — more targeted than topicals, less invasive than surgery, without hormonal side effects.
Frequently Asked Questions
Yes. The Hairgenetix system uses 24-karat gold micro-needles with controlled 1–2mm penetration depth, designed specifically for safe self-application. All serums are sterile, single-use vials. Follow the included instructions carefully.
Most users report reduced shedding within 4–6 weeks. Visible new growth typically appears between 2–4 months. In our clinical trial, 75% of participants saw visible improvement by day 90.
Many users combine mesotherapy with other treatments. Copper peptides work through different pathways than minoxidil (vasodilation) or finasteride (DHT blocking), so they can complement each other. Consult your doctor before combining treatments.
Our clinical trial included participants with androgenetic alopecia, telogen effluvium, and diffuse thinning. Results were positive across all types. However, mesotherapy cannot regrow hair where follicles are completely scarred (cicatricial alopecia).
The recommended protocol is once weekly for the first 3 months (intensive phase), then once every 2–4 weeks for maintenance. Each box contains 4 vials — a one-month supply during the intensive phase.
How Copper Peptide Treatment Compares
| Treatment | Evidence Level | Side Effects | Mechanism |
|---|---|---|---|
| GHK-Cu Copper Peptides | Moderate (peer-reviewed) | Minimal | Follicle regeneration via Wnt/β-catenin signalling |
| Minoxidil 5% | Strong (FDA approved) | Scalp irritation, initial shedding | Vasodilation, extends anagen phase |
| Finasteride 1mg | Strong (FDA approved) | Sexual side effects (1–2%) | DHT blocker (5α-reductase inhibitor) |
| PRP Therapy | Moderate (clinic-based) | Pain at injection site | Growth factor concentration |
Referencer
- Dhurat R et al. (2013). Randomized evaluator blinded study of effect of microneedling in androgenetic alopecia. Int J Trichology.
- Pickart L et al. (2012). The human tripeptide GHK-Cu in prevention of oxidative stress. Int J Mol Sci.
- Pei S et al. (2024). Microneedling for androgenetic alopecia: a systematic review and meta-analysis. J Cosmet Dermatol.
- Gupta AK et al. (2022). Microneedling for hair loss. J Cosmet Dermatol.
- Gupta AK et al. (2023). Systematic review of mesotherapy for hair loss. J Dermatolog Treat.
- PDRN polynucleotide gel efficacy for pattern hair loss. (2024). Arch Dermatol Res.
Skrevet af Malcolm Smith, Founder of Hairgenetix · Medicinsk gennemgang af Dr. Esther Bodde, Cosmetic & Medical Physician (MD) · Sidst opdateret: marts 2026
Referencer: Pickart et al. 2012 (GHK-Cu) · Mesotherapy Review 2023 · Copper Peptides & Hair 2019
Start din hårfornyelsesrejse i dag
Mesoterapi-sæt til hjemmebrug
Startpakke til hårfornyelse: meso-pen & serumopløsning
Det ultimative hårvækstsystem
Holistisk pleje og pakkeløsning med maksimal effekt
